Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease

Clinical Neurophysiology

Volumn 120, Issue 4, 2009, Pages 709-718

  Babiloni, Claudio ^a,b   Frisoni, Giovanni B ^c   Del Percio, Claudio ^c   Zanetti, Orazio ^c   Bonomini, Cristina ^c   Cassetta, Emanuele ^c   Pasqualetti, Patrizio ^b,c   Miniussi, Carlo ^c,d   De Rosas, Mario ^a   Valenzano, Anna ^a   Cibelli, Giuseppe ^a   Eusebi, Fabrizio ^e,f   Rossini, Paolo M ^b,c,g  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Casa di Cura San Raffaele   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f IRCCS NEUROMED   (Italy)

^g UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Electroencephalography (EEG); Ibuprofen; Low resolution brain electromagnetic tomography (LORETA); Mild Alzheimer's disease (mild AD)

Indexed keywords

ESOMEPRAZOLE; IBUPROFEN; PLACEBO;

AGE DISTRIBUTION; AGED; ALPHA RHYTHM; ALZHEIMER DISEASE; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; DISEASE SEVERITY; EDUCATION; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MINI MENTAL STATE EXAMINATION; NEUROPROTECTION; PRIORITY JOURNAL; SEX DIFFERENCE; THETA RHYTHM; TREATMENT DURATION;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAIN MAPPING; CASE-CONTROL STUDIES; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; IBUPROFEN; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; SPECTRUM ANALYSIS;

EID: 63549113275     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2009.02.005     Document Type: Article

References (119)

1. Aisen P.S., Schafer K.A., Grundman M., Pfeiffer E., Sano M., Davis K.L., et al. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289 21 (2003) 2819-2826
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 3 (2000) 383-421 [review]
3. Anderer P., Saletu B., Semlitsch H.V., and Pascual-Marqui R.D. Non-invasive localization of P300 sources in normal aging and age-associated memory impairment. Neurobiol Aging 24 3 (2003) 463-479
4. Anderer P., Saletu B., Saletu-Zyhlarz G., Gruber D., Metka M., Huber J., et al. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials. Neuropsychobiology 49 3 (2004) 134-153
5. Andersen K., Launer L.J., Ott A., Hoes A.W., Breteler M.M., and Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam study. Neurology 45 8 (1995) 1441-1445
6. Anthony J.C., Breitner J.C., Zandi P.P., Meyer M.R., Jurasova I., Norton M.C., et al. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology 54 11 (2000) 2066-2071
7. Babiloni C., Binetti G., Cassetta E., Cerboneschi D., Dal Forno G., Del Percio C., et al. Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multi-centric EEG study. NeuroImage 22 1 (2004) 57-67
8. Babiloni C., Binetti G., Cassarino A., Dal Forno G., Del Percio C., Ferreri F., et al. Sources of cortical rhythms in adults during physiological aging: a multi-centric EEG study. Hum Brain Mapp 27 2 (2006) 162-172
9. Babiloni C., Binetti G., Cassetta E., Dal Forno G., Del Percio C., Ferreri F., et al. Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multi-centric study. Clin Neurophysiol 117 2 (2006) 252-268
10. Babiloni C., Benussi L., Binetti G., Bosco P., Busonero G., Cesaretti S., et al. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study. Neuroimage 29 3 (2006) 948-964
11. Babiloni C., Benussi L., Binetti G., Cassetta E., Dal Forno G., Del Percio C., et al. Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: a multicentric EEG study. Ann Neurol 59 2 (2006) 323-334
12. Babiloni C., Frisoni G., Steriade M., Bresciani L., Binetti G., Del Percio C., et al. Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol 117 5 (2006) 1113-1129
13. Babiloni C., Cassetta E., Dal Forno G., Del Percio C., Ferreri F., Ferri R., et al. Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: responders vs. non-responders. Neuroimage 31 4 (2006) 1650-1665
14. Babiloni C., Squitti R., Del Percio C., Cassetta E., Ventriglia M.C., Ferreri F., et al. Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects. Clin Neurophysiol 118 6 (2007) 1244-1260
15. Babiloni C., Cassetta E., Binetti G., Tombini M., Del Percio C., Ferreri F., et al. Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease. Eur J Neurosci 25 12 (2007) 3742-3757
16. Babiloni C., Bosco P., Ghidoni R., Del Percio C., Squitti R., Binetti G., et al. Homocysteine and EEG rhythms in Alzheimer disease: a multicentric study. Neuroscience 145 3 (2007) 942-954
17. Babiloni C., Frisoni G., Pievani M., Toscano L., Del Percio C., Geroldi C., et al. White matter vascular lesions correlate with alpha EEG sources in mild cognitive impairment. Neuropsychologia 46 6 (2008) 1707-1720
18. Barone P., Burn D.J., van Laar T., Hsu C., Poewe W., and Lane R.M. Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. Mov Disord 23 11 (2008) 1532-1540
19. Beard C.M., Kottke T.E., Annegers J.F., and Ballard D.J. The Rochester coronary heart disease project: effect of cigarette smoking, hypertension, diabetes, and steroidal estrogen use on coronary heart disease among 40- to 59-year-old women, 1960 through 1982. Mayo Clin Proc 64 12 (1989) 1471-1480
20. Berg L., Miller J.P., Storandt M., Duchek J., Morris J.C., Rubin E.H., et al. Mild senile dementia of the Alzheimer's type. 2: Longitudinal assessment. Ann Neurol 23 (1988) 477-484
21. Besthorn C., Zerfass R., Geiger-Kabisch C., Sattel H., Daniel S., Schreiter-Gasser U., et al. Discrimination of Alzheimer's disease and normal aging by EEG data. Electroencephalogr Clin Neurophysiol 103 2 (1997) 241-248
22. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1 (2006) CD005593 [review]
23. Birks J., and Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 3 (2006) CD006104 [review]
24. Brassen S., and Adler G. Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial. Pharmacopsychiatry 36 (2003) 304-308
25. Broe G.A., Grayson D.A., Creasey H.M., Waite L.M., Casey B.J., Bennett H.P., et al. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Arch Neurol 57 11 (2000) 1586-1591
26. Buzsaki G., Bickford R.G., Ponomareff G., Thal L.J., Mandel R., and Gage F.H. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 8 11 (1988) 4007-4026
27. Chiaramonti R., Muscas G.C., Paganini M., Muller T.J., Fallgatter A.J., Versari A., et al. Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type. Neuropsychobiology 36 3 (1997) 153-158
28. Cook I.A., and Leuchter A.F. Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG. Behav Brain Res 78 1 (1996) 15-23
29. Cummings J.L., Mega M., Gray K., Rosenberg-Thompson S., Carusi D.A., and Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44 (1994) 2308-2314
30. deJongh A., Baayen J.C., de Munck J.C., Heethaar R.M., Vandertop W.P., and Stam C.J. The influence of brain tumor treatment on pathological delta activity in MEG. Neuroimage 20 4 (2003) 2291-2301
31. Dierks T., Ihl R., Frolich L., and Maurer K. Dementia of the Alzheimer type: effects on the spontaneous EEG described by dipole sources. Psychiatry Res 50 3 (1993) 51-162
32. Dierks T., Jelic V., Pascual-Marqui R.D., Wahlund L.O., Julin P., Linden D.E.J., et al. Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol 111 (2000) 1817-1824
33. Dringenberg H.C. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115 (2000) 235-249
34. Dringenberg H.C., Rubenstein M.L., Solty H., Tomaszek S., and Bruce A. Electroencephalographic activation by tacrine, deprenyl, and quipazine: cholinergic vs. non-cholinergic contributions. Eur J Pharmacol 447 1 (2002) 43-50
35. Ebert U., and Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest 28 11 (1998) 944-949 [review]
36. Fernandez A., Arrazola J., Maestu F., Amo C., Gil-Gregorio P., Wienbruch C., et al. Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. Am J Neuroradiol 24 3 (2003) 481-487
37. Fioravanti M., Nacca D., Buckley A.E., Ferrario E., Varetto O., Mogni P., et al. The Italian version of the Alzheimer's disease assessment scale (ADAS): psychometric and normative characteristics from a normal aged population. Arch Gerontol Geriatr 19 1 (1994) 21-30
38. Folstein M.F., Folstein S.E., and McHugh P.R. 'Mini Mental State': a practical method for grading the cognitive state of patients for clinician. J Psychiat Res 12 (1975) 189-198
39. Frisoni G.B., Beltramello A., Binetti G., Bianchetti A., Weiss C., Scuratti A., et al. Computed tomography in the detection of the vascular component in dementia. Gerontology 41 2 (1995) 121-128
40. Galluzzi S., Sheu C.F., Zanetti O., and Frisoni G.B. Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease. Dement Geriatr Cogn Disord 19 4 (2005) 196-203
41. Geula C., and Mesulam M.M. Cortical cholinerigc fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 33 (1989) 469-481
42. Geula C., and Mesulam M.M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb Cortex 6 (1996) 165-177
43. Geula C., and Mesulam M.M. Cholinergic system in Alzheimer's disease. In: Terry R.D., et al. (Ed). Alzheimer disease. 2nd ed. (1999), Williams and Wilkins, Lippincot, Philadelphia, PA 69-292
44. Gloor P., Ball G., and Schaul N. Brain lesions that produce delta waves in the EEG. Neurology 27 4 (1977) 326-333
45. Harmony T., Fernandez-Bouzas A., Marosi E., Fernandez T., Bernal J., Rodriguez M., et al. Correlation between computed tomography and voltage and current source density spectral EEG parameters in patients with brain lesions. Electroencephalogr Clin Neurophysiol 87 4 (1993) 196-205
46. Harrison J.E. Measuring cognitive change in Alzheimer's disease clinical drug trials. J Nutr Health Aging 11 4 (2007) 327-329 [review]
47. Helkala E.L., Hanninen T., Hallikainen M., Kononen M., Laakso M.P., Hartikainen P., et al. Slow-wave activity in the spectral analysis of the electroencephalogram and volumes of hippocampus in subgroups of Alzheimer's disease patients. Behav Neurosci 110 6 (1996) 1235-1243
48. Henderson A.S., Jorm A.F., Christensen H., Jacomb P.A., and Korten A.E. Aspirin, anti-inflammatory drugs and risk of dementia. Int J Geriatr Psychiatry 12 9 (1997) 926-930
49. Hensel S., Rockstroh B., Berg P., Elbert T., and Schonle P.W. Left-hemispheric abnormal EEG activity in relation to impairment and recovery in aphasic patients. Psychophysiology 41 3 (2004) 394-400
50. Holschneider D.P., Waite J.J., Leuchter A.F., Walton N.Y., and Scremin O.U. Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin. Exp Brain Res 126 2 (1999) 270-280
51. Huang C., Wahlund L.O., Dierks T., Julin P., Winblad B., and Jelic V. Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study. Clin Neurophysiol 11 (2000) 1961-1967
52. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
53. In 't Veld B.A., Launer L.J., Hoes A.W., Ott A., Hofman A., Breteler M.M., et al. NSAIDs and incident Alzheimer's disease. The Rotterdam study. Neurobiol Aging 19 (1998) 607-611
54. Jelic V., Shigeta M., and Julin P. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 7 (1996) 314-323
55. Jelic V., Johansson S.E., Almkvist O., Shigeta M., Julin P., Nordberg A., et al. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 21 (2000) 533-540
56. Jeong J. EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 115 7 (2004) 1490-1505
57. Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 31 (1983) 721-727
58. Katz I.R. Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias. J Clin Psychiatry 59 suppl 9 (1998) 38-44
59. Klimesch W. Memory processes, brain oscillations and EEG synchronization. Int J Psychophysiol 24 1-2 (1996) 61-100
60. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Rev 29 (1999) 169-195
61. Klimesch W., Doppelmayr M., Pachinger T., and Russegger H. Event-related desynchronization in the alpha band and the processing of semantic information. Brain Res Cogn Brain Res 6 2 (1997) 83-94
62. Klimesch W., Doppelmayr M., Russegger H., Pachinger T., and Schwaiger J. Induced alpha band power changes in the human EEG and attention. Neurosci Lett 244 2 (1998) 73-76
63. Kobayashi Y., and Tadashi I. Sensory-motor gating and cognitive control by the brainstem cholinergic system. Neural Networks (2002) 731-741
64. Kogan E.A., Korczyn A.D., Virchowsy R.G., Klimovizky S.Sh., Treves T.A., and Neufeld M.Y. EEG changes during long-term treatment with donepezil in Alzheimer's disease patients. J Neural Transm 108 (2001) 1167-1173
65. Kolev V., Yordanova J., Basar-Eroglu C., and Basar E. Age effects on visual EEG responses reveal distinct frontal alpha networks. Clin Neurophysiol 113 6 (2002) 901-910
66. Laufer I., and Pratt H. Evoked potentials to auditory movement sensation in duplex perception. Clin Neurophysiol 114 7 (2003) 1316-1331
67. Lawton M.P., and Brodie E.M. Assessment of older people: self maintaining and instrumental activity of daily living. J Gerontol 9 (1969) 179-186
68. Leuchter A.F., Cook I.A., Newton T.F., Dunkin J., Walter D.O., Rosenberg Tompson S., et al. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroenceph Clin Neurophysiol 87 (1993) 385-393
69. Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20 (2000) 5709-5714
70. Mash D.C., Flynn D.D., and Potter L.T. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228 4703 (1985) 1115-1117 31
71. Maurer K., and Dierks T. Functional imaging procedures in dementias: mapping of EEG and evoked potentials. Acta Neurol Scand Suppl 139 (1992) 40-46
72. McKeith I.G., Perry E.K., and Perry R.H. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortiumon dementia with Lewy bodies. Neurology 53 (1999) 902-925
73. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
74. Mesulam M., Shaw P., Mash D., and Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55 6 (2004) 815-828
75. Moretti D.V., Babiloni F., Carducci F., Cincotti F., Remondini E., Rossini P.M., et al. Computerized processing of EEG-EOG-EMG artifacts for multicentirc studies in EEG oscillations and event-related potentials. Int J Pshycophysiol 47 3 (2003) 199-216
76. Mulert C., Gallinat J., Pascual-Marqui R., Dorn H., Frick K., Schlattmann P., et al. Reduced event-related current density in the anterior cingulate cortex in schizophrenia. Neuroimage 13 4 (2001) 589-600
77. Murri L., Gori S., Massetani R., Bonanni E., Marcella F., and Milani S. Evaluation of acute ischemic stroke using quantitative EEG: a comparison with conventional EEG and CT scan. Neurophysiol Clin 28 3 (1998) 249-257
78. Nobili F., Taddei G., Vitali P., Bazzano L., Catsafados E., Mariani G., et al. Relationships between 99m Tc-HMPAO ceraspect and quantitative EEG observations in Alzheimer's disease. Arch Gerontol Geriatr 6 (1998) 363-368
79. Nuwer M.R. Quantitative EEG. I : techniques and problems of frequency analysis and topographic mapping. J Clin Neurophysiol 5 (1998) 1-43
80. Onofrj M., Thomas A., Iacono D., Luciano A.L., and Di Iorio A. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia. Clin Neuropharmacol 26 (2003) 239-251
81. Pascual-Marqui R.D., and Michel C.M. LORETA (low resolution brain electromagnetic tomography): new authentic 3D functional images of the brain. ISBET Newsletter ISSN 5 (1994) 4-8
82. Pascual-Marqui R.D., Lehmann D., Koenig T., Kochi K., Merlo M.C., Hell D., et al. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Res 90 3 (1999) 169-179
83. Pascual-Marqui R.D., Esslen M., Kochi K., and Lehmann D. Functional imaging with low resolution brain electromagnetic tomography (LORETA): a review. Methods Find Exp Clin Pharmacol 24 (2002) 91-95
84. Phillips C., Rugg M.D., and Friston K.J. Systemic regularization of linear inverse solutions of the EEG source localization problem. Neuroimage 17 (2002) 287-301
85. Ponomareva N.V., Selesneva N.D., and Jarikov G.A. EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology 48 3 (2003) 152-159
86. Prichep L.S., John E.R., Ferris S.H., Reisberg B., Almas M., Alper K., et al. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging 15 1 (1994) 85-90
87. Prichep LS, John ER, Ferris SH, Reisberg B, Almas M, et al. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging 1994;15(1):85-90 [Erratum in: Neurobiol Aging 1994;15(3):391].
88. Pucci E., Cacchiò G., Angeloni R., Belardinelli N., Nolfe G., Signorino M., et al. EEG spectral analysis in Alzheimer's disease and different degenerative dementias. Arch Gereontol Geriat 26 (1997) 283-297
89. Ray P.G., and Jackson W.J. Lesions of nucleus basalis alter ChAT activity and EEG in rat frontal neocortex. Electroencephalogr Clin Neurophysiol 79 1 (1991) 62-68
90. Reeves R.R., Struve F.A., and Patrick G. The effects of donepezil on quantitative EEG in patients with Alzheimer's disease. Clin Electroencephalogr 33 2 (2002) 93-96
91. Reines S.A., Block G.A., Morris J.C., Liu G., Nessly M.L., Lines C.R., et al. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology 62 1 (2004) 66-71
92. Rodriguez G., Nobili F., Rocca G., DeCarli F., Gianelli M.V., and Rosadini G. Quantitative electroencephalography and regional cerebral blood flow: discriminant analysis between Alzheimer's patients and healthy controls. Dement Geriatr Cogn Disord 9 (1998) 238-274
93. Rodriguez G., Copello F., Nobili F., Vitali P., Perego G., and Nobili F. EEG spectral profile to stage Alzheimer's disease. Clin Neurophysiol 110 (1999) 1831-1837
94. Rodriguez G., Vitali P., De Leo C., De Carli F., Girtler N., and Nobili F. Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. Neuropsychobiology 46 (2002) 49-56
95. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 43 8 (1993) 1609-1611
96. Román G.C., Tatemichi T.K., Erkinjuntti T., Cummings J.L., Masdeu J.C., Garcia J.H., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43 2 (1993) 250-260
97. Rossini P.M., Rossi S., Babiloni C., and Polich J. Clinical neurophysiology of aging brain: from normal aging to neurodegeneration. Prog Neurobiol 83 6 (2007) 375-400 [Epub 2007 August 8; Review December]
98. Rozzini L., Vicini Chilovi B., Bertoletti E., Conti M., Delrio I., Trabucchi M., et al. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. J Geriatr Psychiatry Neurol 21 4 (2008) 261-267
99. Sarter M., and Bruno J.P. Mild cognitive impairment and the cholinergic hypothesis: a very different take on recent data. Ann Neurol 52 3 (2002) 384-385
100. Scharf S., Mander A., Ugoni A., Vajda F., and Christophidis N. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology 53 1 (1999) 197-201
101. Schreiter-Gasser U., Gasser T., and Ziegler P. Quantitative EEG analysis in early onset Alzheimer's disease: a controlled study. Electroencephalogr Clin Neurophysiol 86 1 (1993) 15-22
102. Sloan E.P., Fenton G.W., Kennedy N.S.J., and MacLennan J.M. Electroencephalography and single photon emission computed tomography in dementia: a comparative study. Psychol Med 25 (1995) 631-638
103. Soininen H., West C., Robbins J., and Niculescu L. Long-term efficacy and safety of celecoxib in Alzheimer's disease. Dement Geriatr Cogn Disord 23 1 (2007) 8-21
104. Speilberger C.D. Manual for the state-trait anxiety inventory (Form Y-1) (1983), Consulting Psychologists Press, Palo Alto, CA
105. Steriade M. Neuronal substrates of sleep and epilepsy (2003), Cambridge University Press, Cambridge (UK) p. 522
106. Steriade M., Amzica F., and Contreras D. Synchronization of fast (30-40 Hz) spontaneous cortical rhythms during brain activation. J Neurosci 16 (1996) 392-417
107. Stewart G.R., Frederickson C.J., Howell G.A., and Gage F.H. Cholinergic denervation-induced increase of chelatable zinc in mossy-fiber region of the hippocampal formation. Brain Res 290 1 (1984) 43-51
108. Stewart W.F., Kawas C., Corrada M., and Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48 3 (1997) 626-632
109. Szelies B., Grond M., Herholz K., Kessler J., Wullen T., and Heiss W.D. Quantitative EEG mapping and PET in Alzheimer's disease. J Neurol Sci 110 (1992) 46-56
110. Talairach J., and Tournoux P. Co-planar stereotaxic atlas of the human brain (1988), Thieme, Stuttgart
111. Tanaka Y., Hanyu H., Sakurai H., Takasaki M., and Abe K. Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients. Dement Geriatr Cogn Disord 16 (2003) 119-125
112. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-18.
113. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414 6860 (2001) 212-216
114. Wesnes K.A. Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's disease assessment scale-cognitive subscale and the cognitive drug research system. Neurodegener Dis 5 3-4 (2008) 261-263
115. Wolf H., Jelic V., Gertz H.J., Nordberg A., Julin P., and Wahlund L.O. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand 107 Suppl. 179 (2003) 52-76
116. Yao D., and He B. A self-coherence enhancement algorithm and its application to enhancing three-dimensional source estimation from EEGs. Ann Biomed Eng 29 (2001) 1019-1027
117. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17 1 (1982) 37-49 83
118. Zandi P.P., Anthony J.C., Hayden K.M., Mehta K., Mayer L., and Breitner J.C. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County study. Neurology 59 6 (2002) 880-886
119. Zanetti O., Bonomini C., Pasqualetti P., Milazzo D., Paulon L., Dal F., et al. Effects of ibuprofen on Alzheimer's disease cognitive progression: a randomized controlled trial. Alzheimer's Dementia 2 (2006) P2407 S366